Lyra Influenza A+B Assay

FDA 510(k) K230236 · Quidel Corporation

Substantially Equivalent

510(k) numberK230236

Submission

Device name
Lyra Influenza A+B Assay
Applicant
Quidel Corporation
San Diego, CA, US
Received
January 30, 2023
Decision date
March 3, 2023
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
OZE – Influenza A And Influenza B Multiplex Nucleic Acid Assay
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3980
Specialty
Microbiology

An Influenza A and Influenza B multiplex nucleic acid assay is a multiplex in vitro diagnostic test for the simultaneous qualitative detection and discrimination of influenza A and influenza B nucleic acids isolated and purified from human respiratory specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections or viral culture. The detection and…

Other 510(k)s with product code OZE

510(k)DeviceApplicantDecision
K243274CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit…OZE · Traditional Centers for Disease Control and Prevention07/11/2025SE
K243931CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit…OZE · Traditional Centers for Disease Control and Prevention03/14/2025SE
K241110CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel, Influenza A Subtyping Kit…OZE · Special Centers for Disease Control and Prevention05/21/2024SE
K220801ID Now Instrument, ID Now Influenza A & B 2, ID NOW Strep A 2OZE · Special Abbott Diagnostics Scarborough, Inc.06/24/2022SE
K200370CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A/B Typing Kit…OZE · Special Centers for Disease Control and Prevention03/10/2020SE
K182513FluChip-8G Influenza A+B AssayOZE · Traditional Indevr, Inc.04/22/2019SE
K190302CDC Human Influenza Virus Real-time RT-PCR Diagnostic Panel, Influenza A/B Typing Kit…OZE · Traditional Centers for Disease Control and Prevention03/27/2019SE
K190204ID NOW Influenza A & B 2OZE · Special Alere Scarborough, Inc.03/18/2019SE
K181736CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza B Lineage…OZE · Special Centers For Disease Control and Prevention (CDC)07/30/2018SE
K171641Accula Flu A/Flu B TestOZE · Dual Track Mesa Biotech, Inc.02/06/2018SE

More from Mesa Biotech, Inc.

510(k)DeviceDecision
K231795QuickVue COVID-19 TestQYT · Traditional 03/22/2024SE
K232286Savanna HSV 1+2/VZV Assay, Savanna HSV 1+2/VZV Control Set, Savanna InstrumentPGI · Traditional 12/20/2023SE
K233688Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab SetQVF · Special 12/13/2023SE
K230349Lyra RSV+hMPV AssayOEM · Special 03/10/2023SE
K211342Sofia 2 Campylobacter FIALQP · Traditional 11/23/2021SE
K173496Sofia 2 Lyme FIA, Sofia Lyme Control SetLSR · Dual Track 08/30/2018SE
K181029Solana Bordetella Complete AssayOZZ · Traditional 07/15/2018SE
K173691Sofia Lyme FIA, Sofia 2 analyzer, Sofia 2 Installation PackLSR · Traditional 02/28/2018SE
K180288QuickVue Influenza A+BPSZ · Special 02/13/2018SE
K173250Solana GBS AssayNJR · Traditional 12/21/2017SE

Questions and answers

When was Lyra Influenza A+B Assay cleared by the FDA?

Lyra Influenza A+B Assay (K230236) received a 510(k) decision of Substantially Equivalent on March 3, 2023, 32 days after the submission was received.

What is the product code of K230236?

The FDA product code is OZE – Influenza A And Influenza B Multiplex Nucleic Acid Assay, a Class II (moderate risk) device regulated under 21 CFR 866.3980.